Layer-by-layer (LbL) self-assembled stacked Testudo -like MoS 2 superstructures carrying cancer drugs are formed from nanosheets controllably assembled with sequence-based DNA oligonucleotides. These superstructures can disassemble autonomously in response to cancer cells’ heightened ATP metabolism. First, we functionalize MoS 2 nanosheets (MoS 2 -NS) nanostructures with DNA oligonucleotides having thiol-terminated groups (DNA/MoS 2 -NS) via strong binding to sulfur atom defect vacancies on MoS 2 surfaces. The driving force to assemble into a higher-order DNA/MoS 2 -NS superstructure is guided by a linker aptamer that induced interlayer assembly. In the presence of target ATP molecules, these multilayer superstructures disassembled as a consequence of stronger binding of ATP molecules with the linking aptamers. This design plays a dual role of protection and delivery by LbL stacked MoS 2 -NS similar in concept to a Greek Testudo . These superstructures present a protective armor-like shell of MoS 2 -NS, which still remains responsive to small and infiltrating ATP molecules diffusing through the protective MoS 2 -NS, contributing to an enhanced stimuli-responsive drug release system for targeted chemotherapy.
No takes yet. Share an insight, caveat, or question.
Li et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: